348 related articles for article (PubMed ID: 18198072)
1. [Visceral leishmaniasis and HIV infection in the HAART era].
Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
[TBL] [Abstract][Full Text] [Related]
2. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
4. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
[TBL] [Abstract][Full Text] [Related]
5. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
[TBL] [Abstract][Full Text] [Related]
6. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.
Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A
Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426
[TBL] [Abstract][Full Text] [Related]
8. [Visceral leishmaniasis in patients with HIV infection].
Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C
Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130
[TBL] [Abstract][Full Text] [Related]
9. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
Pourahmad M; Hooshmand F; Rahiminejad M
Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
[TBL] [Abstract][Full Text] [Related]
12. [Intestinal parasitic infections and leishmaniasis in patients with HIV infection].
Moreno-Camacho A; López-Vélez R; Muñoz Sanz A; Labarga-Echevarría P
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():52-60. PubMed ID: 9859620
[TBL] [Abstract][Full Text] [Related]
13. Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Patel TA; Lockwood DN
Trop Med Int Health; 2009 Sep; 14(9):1064-70. PubMed ID: 19552658
[TBL] [Abstract][Full Text] [Related]
14. [Leishmaniasis and human immunodeficiency virus: an emerging co-infection?].
Marlier S; Menard G; Gisserot O; Kologo K; De Jaureguiberry JP
Med Trop (Mars); 1999; 59(2):193-200. PubMed ID: 10546196
[TBL] [Abstract][Full Text] [Related]
15. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis in patient with HIV infection].
Olea P; Pinilla J
Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of visceral leishmaniasis in HIV infection.
Jarvis JN; Lockwood DN
Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
[TBL] [Abstract][Full Text] [Related]
18. Leishmania / HIV co-infections.
Desjeux P
Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
[TBL] [Abstract][Full Text] [Related]
19. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.
de la Rosa R; Pineda JA; Delgado J; Macías J; Morillas F; Martín-Sánchez J; Leal M; Sánchez-Quijano A; Lissen E
Clin Infect Dis; 2001 Feb; 32(4):633-5. PubMed ID: 11181128
[TBL] [Abstract][Full Text] [Related]
20. [Clinical signs of visceral leishmaniasis in adults: is the manner of presentation changing?].
Gaeta GB
Parassitologia; 2004 Jun; 46(1-2):225-6. PubMed ID: 15305722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
